Coalition for Pulmonary Fibrosis Celebrates Landmark Year for Awareness, Advocacy, Research

SAN JOSE, Calif. Dec. 31 — The Coalition for Pulmonary Fibrosis (CPF) calls 2008 a year of substantial progress in advocacy, research support and awareness of a fatal disease that has no known cause, no FDA-approved treatment, and no cure — Pulmonary Fibrosis (PF).

The CPF was able to double its research grant funding through a partnership with the American Thoracic Society (ATS). The CPF/ATS partnership enables the search for treatments to assist patients who are suffering from this relentless and ultimately fatal disease. As many as 40,000 patients die each year to PF - the same number as are lost to breast cancer.